1-20 of 29
follow-up
Close
Sort by
Journal Articles

Evidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies

Richard J. Lin, Heidi D. Klepin
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 59–62.
https://doi.org/10.1182/hematology.2019000076
Published: 2019
Journal Articles

Cure at what (systemic) financial cost? Integrating novel therapies into first-line Hodgkin lymphoma treatment

Scott F. Huntington
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 252–259.
https://doi.org/10.1182/hematology.2019000030
Published: 2019
Journal Articles

Where does PD-1 blockade fit in HL therapy?

Alex F. Herrera
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 213–220.
https://doi.org/10.1182/asheducation-2018.1.213
Published: 2018
Journal Articles

TTP: long-term outcomes following recovery

James N. George
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 548–552.
https://doi.org/10.1182/asheducation-2018.1.548
Published: 2018
Journal Articles

Treatment-free remission in CML: who, how, and why?

Francois-Xavier Mahon
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 102–109.
https://doi.org/10.1182/asheducation.V2017.1.102.00014
Published: 2017
Journal Articles

Emerging role of novel therapies in Hodgkin lymphoma: proceed with caution

Nancy L. Bartlett
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 317–323.
https://doi.org/10.1182/asheducation-2017.1.317
Published: 2017
Journal Articles

Hereditary thrombocytopenias: a growing list of disorders

Patrizia Noris, Alessandro Pecci
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 385–399.
https://doi.org/10.1182/asheducation-2017.1.385
Published: 2017
Journal Articles

Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly

Marco Ruella, Pierre Soubeyran
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 432–436.
https://doi.org/10.1182/asheducation-2016.1.432
Published: 2016
Journal Articles

Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment

Flora E. van Leeuwen, Andrea K. Ng
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 323–330.
https://doi.org/10.1182/asheducation-2016.1.323
Published: 2016
Journal Articles

Nontransplant therapy for bone marrow failure

Danielle M. Townsley, Thomas Winkler
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 83–89.
https://doi.org/10.1182/asheducation-2016.1.83
Published: 2016
Journal Articles

Does hydroxyurea prevent pulmonary complications of sickle cell disease?

Tyler W. Buckner, Kenneth I. Ataga
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 432–437.
https://doi.org/10.1182/asheducation-2014.1.432
Published: 2014
Journal Articles

Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects

Andrea K. Ng
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 488–494.
https://doi.org/10.1182/asheducation-2014.1.488
Published: 2014
Journal Articles

Caring for the long-term survivor after allogeneic stem cell transplantation

Smita Bhatia
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 495–503.
https://doi.org/10.1182/asheducation-2014.1.495
Published: 2014
Journal Articles

Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemia

Richard F. Schlenk, Hartmut Döhner
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 324–330.
https://doi.org/10.1182/asheducation-2013.1.324
Published: 2013
Journal Articles

Is there a role for warfarin anymore?

Alan Jacobson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 541–546.
https://doi.org/10.1182/asheducation.V2012.1.541.3798556
Published: 2012
Journal Articles

Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes

James N. George, Zayd L. Al-Nouri
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 604–609.
https://doi.org/10.1182/asheducation.V2012.1.604.3798564
Published: 2012
Journal Articles

How to use new biology to guide therapy in multiple myeloma

Gareth J. Morgan, Martin F. Kaiser
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 342–349.
https://doi.org/10.1182/asheducation.V2012.1.342.3798324
Published: 2012
Journal Articles

What is the evidence that hydroxyurea improves health-related quality of life in patients with sickle cell disease?

Deepika S. Darbari, Julie A. Panepinto
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 290–291.
https://doi.org/10.1182/asheducation.V2012.1.290.3798273
Published: 2012
Journal Articles

Low blood counts: immune mediated, idiopathic, or myelodysplasia

Peter Valent
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 485–491.
https://doi.org/10.1182/asheducation.V2012.1.485.3798522
Published: 2012
Journal Articles

Fanconi Anemia

Jean Soulier
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 492–497.
https://doi.org/10.1182/asheducation-2011.1.492
Published: 2011